BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19031627)

  • 1. [Management of cervical cancer].
    Delpech Y; Barranger E
    J Gynecol Obstet Biol Reprod (Paris); 2008 Jul; 37 Spec No 2():F51-6. PubMed ID: 19031627
    [No Abstract]   [Full Text] [Related]  

  • 2. A retrospective review of patients with stage IB2 cervical cancer treated with radical radiation versus radical surgery as a primary modality.
    Alleyne-Mike K; van Wijk L; Hunter A
    Int J Gynecol Cancer; 2013 Sep; 23(7):1287-94. PubMed ID: 23863456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative prognostic factors and effects of adjuvant therapy on outcomes of early stage cervical cancer in Iran.
    Behtash N; Karimi Zarchi M; Deldar M
    Asian Pac J Cancer Prev; 2009; 10(4):613-8. PubMed ID: 19827880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on Radiation Oncology-Gynecology.
    Gaffney DK; Erickson-Wittmann BA; Jhingran A; Mayr NA; Puthawala AA; Moore D; Rao GG; Small W; Varia MA; Wolfson AH; Yashar CM; Yuh W; Cardenes HR
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):609-14. PubMed ID: 21215531
    [No Abstract]   [Full Text] [Related]  

  • 6. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
    Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY
    J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult invasive cervical cancer found after inadvertent simple hysterectomy: is the ideal management: systematic parametrectomy with or without radiotherapy or radiotherapy only?
    Narducci F; Merlot B; Bresson L; Katdare N; Le Tinier F; Cordoba A; Fournier C; Leblanc E
    Ann Surg Oncol; 2015 Apr; 22(4):1349-52. PubMed ID: 25297903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of stage I and II uterine cervix cancer. Round table].
    Dargent D; Durand JC; Michel G; Pourquier H; Rudigoz RC; Senèze J
    Rev Fr Gynecol Obstet; 1985 Apr; 80(5):299-322. PubMed ID: 4023538
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation and therapy of carcinoma of the uterine cervix.
    van Nagell JR; Donaldson ES; Hanson MB
    Curr Probl Cancer; 1983 Nov; 8(5):1-41. PubMed ID: 6357639
    [No Abstract]   [Full Text] [Related]  

  • 10. Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer.
    Kim SW; Chun M; Ryu HS; Chang SJ; Kong TW; Lee EJ; Lee YH; Oh YT
    Strahlenther Onkol; 2017 Jul; 193(7):534-542. PubMed ID: 28357468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [To reduce uncontrolled and recurrent cervical cancer].
    Cao ZY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Apr; 48(4):302-3. PubMed ID: 23902817
    [No Abstract]   [Full Text] [Related]  

  • 12. [Taxol in advanced cervical cancer].
    Hirabayashi K; Ito J; Kobayashi M; Numa F; Ito T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():179-82. PubMed ID: 15535229
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
    Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
    Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery.
    Ferrandina G; Margariti PA; Smaniotto D; Petrillo M; Salerno MG; Fagotti A; Macchia G; Morganti AG; Cellini N; Scambia G
    Gynecol Oncol; 2010 Dec; 119(3):404-10. PubMed ID: 20817228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multivariate analysis of histopathologic prognostic factors in invasive cervical carcinoma treated with radical hysterectomy including paraaortic lymphadenectomy].
    Takeda N
    Hokkaido Igaku Zasshi; 2003 Jan; 78(1):67-74. PubMed ID: 12613025
    [No Abstract]   [Full Text] [Related]  

  • 16. Early cervical carcinoma: how to manage high-risk patients after radical hysterectomy.
    Samlal RA; van der Velden J
    Eur J Obstet Gynecol Reprod Biol; 1999 Aug; 85(2):137-9. PubMed ID: 10610327
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lymphatic metastasis in patients with invasive cervical carcinoma after initial treatment].
    Lou HM; Li Q
    Ai Zheng; 2007 Nov; 26(11):1248-51. PubMed ID: 17991327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and treatment of patients with invasive cervical cancer.
    van Nagell JR; Donaldson ES; Gay EC
    Surg Clin North Am; 1978 Feb; 58(1):67-85. PubMed ID: 347604
    [No Abstract]   [Full Text] [Related]  

  • 19. Regarding a series of IB bulky cervical cancer treated with neoadjuvant chemotherapy (NACT) and radical hysterectomy and pelvic lymphadenectomy.
    Bolis G; Villa A; Guarnerio P; Acerboni S; Parazzini F
    Gynecol Oncol; 1996 Apr; 61(1):156-8. PubMed ID: 8626108
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer of the cervix.
    Thompson LJ
    Semin Oncol Nurs; 1990 Aug; 6(3):190-7. PubMed ID: 2204973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.